Global Glucose Monitoring Devices Market Overview:
Global Glucose Monitoring Devices Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Glucose Monitoring Devices Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Glucose Monitoring Devices involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Glucose Monitoring Devices Market:
The Glucose Monitoring Devices Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Glucose Monitoring Devices Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Glucose Monitoring Devices Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Glucose Monitoring Devices market has been segmented into:
Self-Monitoring Devices
Continuous Blood Glucose Monitoring Devices
By Application, Glucose Monitoring Devices market has been segmented into:
Hospitals
Home Care
Diagnostic Centers).
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Glucose Monitoring Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Glucose Monitoring Devices market.
Top Key Players Covered in Glucose Monitoring Devices market are:
Abbott Diabetes Care Inc.
ACON Laboratories Inc.
AgaMatrix Inc.
Alive Technologies Pty. Ltd.
ARKRAY Inc.
Ascensia Diabetes Care Holdings AG
B. Braun Melsungen AG
Beurer GmbH
Dexcom Inc.
GlySens Inc.
LifeScan Inc.
Medtronic plc
Nova Biomedical Corporation
Omron Healthcare Co. Ltd.
Roche Diagnostics
Senseonics Holdings Inc.
Terumo Corporation
Trividia Health Inc.
Ypsomed Holding AG
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Glucose Monitoring Devices Market Type
4.1 Glucose Monitoring Devices Market Snapshot and Growth Engine
4.2 Glucose Monitoring Devices Market Overview
4.3 Self-Monitoring Devices
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Self-Monitoring Devices: Geographic Segmentation Analysis
4.4 Continuous Blood Glucose Monitoring Devices
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Continuous Blood Glucose Monitoring Devices: Geographic Segmentation Analysis
Chapter 5: Glucose Monitoring Devices Market Application
5.1 Glucose Monitoring Devices Market Snapshot and Growth Engine
5.2 Glucose Monitoring Devices Market Overview
5.3 Hospitals
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Hospitals: Geographic Segmentation Analysis
5.4 Home Care
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Home Care: Geographic Segmentation Analysis
5.5 Diagnostic Centers).
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Diagnostic Centers).: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Glucose Monitoring Devices Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT DIABETES CARE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; ACON LABORATORIES
6.4 INC.; AGAMATRIX
6.5 INC.; ALIVE TECHNOLOGIES PTY. LTD.; ARKRAY
6.6 INC.; ASCENSIA DIABETES CARE HOLDINGS AG; B. BRAUN MELSUNGEN AG; BEURER GMBH; DEXCOM
6.7 INC.; GLYSENS INC.; LIFESCAN
6.8 INC.; MEDTRONIC PLC; NOVA BIOMEDICAL CORPORATION; OMRON HEALTHCARE CO.
6.9 LTD.; ROCHE DIAGNOSTICS; SENSEONICS HOLDINGS
6.10 INC.; TERUMO CORPORATION; TRIVIDIA HEALTH
6.11 INC.; YPSOMED HOLDING AG
Chapter 7: Global Glucose Monitoring Devices Market By Region
7.1 Overview
7.2. North America Glucose Monitoring Devices Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Self-Monitoring Devices
7.2.2.2 Continuous Blood Glucose Monitoring Devices
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Hospitals
7.2.3.2 Home Care
7.2.3.3 Diagnostic Centers).
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Glucose Monitoring Devices Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Self-Monitoring Devices
7.3.2.2 Continuous Blood Glucose Monitoring Devices
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Hospitals
7.3.3.2 Home Care
7.3.3.3 Diagnostic Centers).
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Glucose Monitoring Devices Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Self-Monitoring Devices
7.4.2.2 Continuous Blood Glucose Monitoring Devices
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Hospitals
7.4.3.2 Home Care
7.4.3.3 Diagnostic Centers).
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Glucose Monitoring Devices Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Self-Monitoring Devices
7.5.2.2 Continuous Blood Glucose Monitoring Devices
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Hospitals
7.5.3.2 Home Care
7.5.3.3 Diagnostic Centers).
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Glucose Monitoring Devices Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Self-Monitoring Devices
7.6.2.2 Continuous Blood Glucose Monitoring Devices
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Hospitals
7.6.3.2 Home Care
7.6.3.3 Diagnostic Centers).
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Glucose Monitoring Devices Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Self-Monitoring Devices
7.7.2.2 Continuous Blood Glucose Monitoring Devices
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Hospitals
7.7.3.2 Home Care
7.7.3.3 Diagnostic Centers).
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Glucose Monitoring Devices Scope:
|
Report Data
|
Glucose Monitoring Devices Market
|
|
Glucose Monitoring Devices Market Size in 2025
|
USD XX million
|
|
Glucose Monitoring Devices CAGR 2025 - 2032
|
XX%
|
|
Glucose Monitoring Devices Base Year
|
2024
|
|
Glucose Monitoring Devices Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Diabetes Care Inc., ACON Laboratories Inc., AgaMatrix Inc., Alive Technologies Pty. Ltd., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Beurer GmbH, Dexcom Inc., GlySens Inc., LifeScan Inc., Medtronic plc, Nova Biomedical Corporation, Omron Healthcare Co. Ltd., Roche Diagnostics, Senseonics Holdings Inc., Terumo Corporation, Trividia Health Inc., Ypsomed Holding AG.
|
|
Key Segments
|
By Type
Self-Monitoring Devices
Continuous Blood Glucose Monitoring Devices
By Applications
Hospitals
Home Care
Diagnostic Centers).
|
